1. Home
  2. SBET vs AMPH Comparison

SBET vs AMPH Comparison

Compare SBET & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$5.39

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.42

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
AMPH
Founded
1995
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
971.8M
IPO Year
2025
2005

Fundamental Metrics

Financial Performance
Metric
SBET
AMPH
Price
$5.39
$18.42
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$18.71
$28.38
AVG Volume (30 Days)
7.7M
604.2K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$28,055,000.00
$719,887,000.00
Revenue This Year
$105.19
$6.90
Revenue Next Year
$13.53
$4.64
P/E Ratio
N/A
$134.36
Revenue Growth
666.04
N/A
52 Week Low
$5.06
$16.65
52 Week High
$40.46
$31.26

Technical Indicators

Market Signals
Indicator
SBET
AMPH
Relative Strength Index (RSI) 42.52 41.27
Support Level $5.06 $17.73
Resistance Level $8.20 $19.81
Average True Range (ATR) 0.34 0.75
MACD 0.03 -0.01
Stochastic Oscillator 40.95 20.23

Price Performance

Historical Comparison
SBET
AMPH

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: